326 related articles for article (PubMed ID: 22886578)
41. Synthesis and in vitro antibacterial activity of novel 3-azabicyclo[3.3.0]octanyl oxazolidinones.
Bhattarai D; Lee SH; Seo SH; Nam G; Kang SB; Pae AN; Kim EE; Oh T; Cho SN; Keum G
Chem Biol Drug Des; 2012 Sep; 80(3):388-97. PubMed ID: 22553981
[TBL] [Abstract][Full Text] [Related]
42. Synthesis and in vitro activity of novel 1,2,4-triazolo[4,3-a]pyrimidine oxazolidinone antibacterial agents. Part II.
Khera MK; Cliffe IA; Prakash O
Bioorg Med Chem Lett; 2011 Sep; 21(18):5266-9. PubMed ID: 21835618
[TBL] [Abstract][Full Text] [Related]
43. Synthesis and preliminary antibacterial evaluation of Linezolid-like 1,2,4-oxadiazole derivatives.
Palumbo Piccionello A; Musumeci R; Cocuzza C; Fortuna CG; Guarcello A; Pierro P; Pace A
Eur J Med Chem; 2012 Apr; 50():441-8. PubMed ID: 22365410
[TBL] [Abstract][Full Text] [Related]
44. Novel 4-N-substituted aryl pent-2-ene-1,4-dione derivatives of piperazinyloxazolidinones as antibacterials.
Lohray BB; Lohray VB; Srivastava BK; Gupta S; Solanki M; Pandya P; Kapadnis P
Bioorg Med Chem Lett; 2006 Mar; 16(6):1557-61. PubMed ID: 16386420
[TBL] [Abstract][Full Text] [Related]
45. Conformational constraint in oxazolidinone antibacterials. Part 2: Synthesis and structure-activity studies of oxa-, aza-, and thiabicyclo[3.1.0]hexylphenyl oxazolidinones.
Renslo AR; Gao H; Jaishankar P; Venkatachalam R; Gómez M; Blais J; Huband M; Vara Prasad JV; Gordeev MF
Bioorg Med Chem Lett; 2006 Mar; 16(5):1126-9. PubMed ID: 16387498
[TBL] [Abstract][Full Text] [Related]
46. Synthesis and antibacterial activity of novel oxazolidinones with methylene oxygen- and methylene sulfur-linked substituents at C5-position.
Rudra S; Sangita F; Gujrati A; Pandya M; Bhateja P; Mathur T; Singhal S; Rattan A; Salman M; Das B
Bioorg Med Chem Lett; 2007 Sep; 17(17):4778-83. PubMed ID: 17618116
[TBL] [Abstract][Full Text] [Related]
47. Synthesis and biological activity of novel antibacterial quinazolines.
Bedi PM; Kumar V; Mahajan MP
Bioorg Med Chem Lett; 2004 Oct; 14(20):5211-3. PubMed ID: 15380229
[TBL] [Abstract][Full Text] [Related]
48. New potential antibacterials: a synthetic route to N-aryloxazolidinone/3-aryltetrahydroisoquinoline hybrids.
Griera R; Cantos-Llopart C; Amat M; Bosch J; del Castillo JC; Huguet J
Bioorg Med Chem Lett; 2006 Feb; 16(3):529-31. PubMed ID: 16275066
[TBL] [Abstract][Full Text] [Related]
49. Recent development of potent analogues of oxazolidinone antibacterial agents.
Michalska K; Karpiuk I; Król M; Tyski S
Bioorg Med Chem; 2013 Feb; 21(3):577-91. PubMed ID: 23273607
[TBL] [Abstract][Full Text] [Related]
50. Antibacterial oxazolidinone analogues having a N-hydroxyacetyl-substituted seven-membered [1,2,5]triazepane or [1,2,5]oxadiazepane C-ring unit.
Suzuki H; Utsunomiya I; Shudo K; Fukuhara N; Iwaki T; Yasukata T
Eur J Med Chem; 2013 May; 63():811-25. PubMed ID: 23584544
[TBL] [Abstract][Full Text] [Related]
51. Water-soluble pleuromutilin derivative with excellent in vitro and in vivo antibacterial activity against gram-positive pathogens.
Hirokawa Y; Kinoshita H; Tanaka T; Nakata K; Kitadai N; Fujimoto K; Kashimoto S; Kojima T; Kato S
J Med Chem; 2008 Apr; 51(7):1991-4. PubMed ID: 18330977
[TBL] [Abstract][Full Text] [Related]
52. Novel piperidinyloxy oxazolidinone antibacterial agents. Diversification of the N-Substituent.
Weidner-Wells MA; Boggs CM; Foleno BD; Melton J; Bush K; Goldschmidt RM; Hlasta DJ
Bioorg Med Chem; 2002 Jul; 10(7):2345-51. PubMed ID: 11983532
[TBL] [Abstract][Full Text] [Related]
53. Novel substituted (pyridin-3-yl)phenyloxazolidinones: antibacterial agents with reduced activity against monoamine oxidase A and increased solubility.
Reck F; Zhou F; Eyermann CJ; Kern G; Carcanague D; Ioannidis G; Illingworth R; Poon G; Gravestock MB
J Med Chem; 2007 Oct; 50(20):4868-81. PubMed ID: 17722903
[TBL] [Abstract][Full Text] [Related]
54. Synthesis and structure-activity relationship studies of highly potent novel oxazolidinone antibacterials.
Komine T; Kojima A; Asahina Y; Saito T; Takano H; Shibue T; Fukuda Y
J Med Chem; 2008 Oct; 51(20):6558-62. PubMed ID: 18826297
[TBL] [Abstract][Full Text] [Related]
55. Discovery of isoxazolinone antibacterial agents. Nitrogen as a replacement for the stereogenic center found in oxazolidinone antibacterials.
Snyder LB; Meng Z; Mate R; D'Andrea SV; Marinier A; Quesnelle CA; Gill P; DenBleyker KL; Fung-Tomc JC; Frosco M; Martel A; Barrett JF; Bronson JJ
Bioorg Med Chem Lett; 2004 Sep; 14(18):4735-9. PubMed ID: 15324898
[TBL] [Abstract][Full Text] [Related]
56. Synthesis and in vitro antibacterial activity of novel methylamino piperidinyl oxazolidinones.
Srivastava BK; Soni R; Patel JZ; Solanki M; Valani D; Gupta S; Mishra B; Takale V; Pandya P; Jain MR; Patel PR
Bioorg Med Chem Lett; 2007 Sep; 17(18):5227-32. PubMed ID: 17624776
[TBL] [Abstract][Full Text] [Related]
57. The synthesis and antibacterial activity of 1,3,4-thiadiazole phenyl oxazolidinone analogues.
Thomasco LM; Gadwood RC; Weaver EA; Ochoada JM; Ford CW; Zurenko GE; Hamel JC; Stapert D; Moerman JK; Schaadt RD; Yagi BH
Bioorg Med Chem Lett; 2003 Dec; 13(23):4193-6. PubMed ID: 14622999
[TBL] [Abstract][Full Text] [Related]
58. Discovery of a novel nitroimidazolyl-oxazolidinone hybrid with potent anti Gram-positive activity: Synthesis and antibacterial evaluation.
Khalaj A; Nakhjiri M; Negahbani AS; Samadizadeh M; Firoozpour L; Rajabalian S; Samadi N; Faramarzi MA; Adibpour N; Shafiee A; Foroumadi A
Eur J Med Chem; 2011 Jan; 46(1):65-70. PubMed ID: 21071113
[TBL] [Abstract][Full Text] [Related]
59. Design, synthesis and biological evaluation of oxazolidinone-quinolone hybrids.
Hubschwerlen C; Specklin JL; Sigwalt C; Schroeder S; Locher HH
Bioorg Med Chem; 2003 May; 11(10):2313-9. PubMed ID: 12713843
[TBL] [Abstract][Full Text] [Related]
60. In Vitro Activities of LCB 01-0648, a Novel Oxazolidinone, against Gram-Positive Bacteria.
Oh SH; Kim J; Baek SY; Chae SE; Park HS; Cho YL; Kwak JH
Molecules; 2017 Mar; 22(3):. PubMed ID: 28273820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
